While IDH mutation is most characteristic of lower-grade infiltrating gliomas, including astrocytomas and oligodendrogliomas, it was in fact the study of GBM that initially led to the discovery of this recurrently altered gene (9). This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).